Pere Barba

13PUBLICATIONS
64CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursAdolescent healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 07, 2024
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma.

Rossana Di Staso, Beatrice Casadei, Frederick L Locke

|Jul 23, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Gloria Tridello

|Apr 26, 2024
Patients with aggressive B-cell lymphoma receiving CAR T-cell therapy have a low rate of severe infections despite lack of universal antibacterial and antifungal prophylaxis.

B Pernas, G Iacoboni, I Los-Arcos

|Sep 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.

Kai Rejeski, Ariel Perez, Gloria Iacoboni

|Nov 09, 2021
Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group.

Anne Mea Spanjaart, Per Ljungman, Rafael de La Camara

|Jun 05, 2021
Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR.

Matthew J Wieduwilt, Wendy Stock, Anjali Advani

Pageof 3

Frequent Collaborators

2 joint publications

Gloria Iacoboni

2 joint publications

Michael Pulsipher

2 joint publications

Matthew J Wieduwilt

2 joint publications

Anjali Advani